Viewing nowLinagliptin Tablets (Linagliptin)
Linagliptin 5mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

MFDS item code 201901237 · Approved 2019.02.26 · Insurance code 656005440
Improvement of blood sugar control in type 2 diabetes
This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be used alone or in combination with other medications to enhance therapeutic effectiveness. Taking this medication can help manage blood sugar levels more steadily, thereby aiding in maintaining a healthy lifestyle.
The recommended dosage of this medication is 5 mg once daily. It can be taken regardless of meals.
This medication should not be used in patients allergic to its main ingredient or any other components. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Caution should be exercised when using this medication together with drugs that can cause hypoglycemia. In particular, when taken with insulin or sulfonylureas, the risk of hypoglycemia may increase, so dosage adjustment may be necessary. This medication should be used with caution in patients with heart failure, and if symptoms of acute pancreatitis occur, the medication should be discontinued immediately and a doctor consulted. Additionally, a rare skin condition resembling bullous pemphigoid may occur, so if blisters or skin lesions develop, the patient should promptly inform a physician. During the course of treatment with this medication, symptoms of hypoglycemia may appear, so it is important to monitor blood sugar levels frequently and respond appropriately to any hypoglycemic symptoms. Use in pregnant or nursing women is not recommended, and safety and efficacy in children and adolescents have not been adequately established and are therefore not recommended. Elderly patients and those with decreased renal and liver function can use this medication without special dosage adjustments, but their condition should be closely monitored. The risk of interactions with other drugs is relatively low; however, caution is needed when used in combination with certain medications. If the patient is taking other medications, they must consult with their doctor or pharmacist. There is no specific antidote in case of overdose, so symptoms should be monitored, and necessary treatment should be received. The medication should be kept out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature.
Pink round film-coated tablets
28 tablets (14 tablets/PTPX2), 30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLinagliptin 5mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Linagliptin 5mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.